GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quest Laboratories Ltd (NSE:QUESTLAB) » Definitions » Intrinsic Value: Projected FCF

Quest Laboratories (NSE:QUESTLAB) Intrinsic Value: Projected FCF : ₹0.00 (As of Jun. 06, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Quest Laboratories Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-06), Quest Laboratories's Intrinsic Value: Projected FCF is ₹0.00. The stock price of Quest Laboratories is ₹84.00. Therefore, Quest Laboratories's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Quest Laboratories's Intrinsic Value: Projected FCF or its related term are showing as below:

NSE:QUESTLAB's Price-to-Projected-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.61
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Quest Laboratories Intrinsic Value: Projected FCF Historical Data

The historical data trend for Quest Laboratories's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Laboratories Intrinsic Value: Projected FCF Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Intrinsic Value: Projected FCF
- - - -

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial - - - - -

Competitive Comparison of Quest Laboratories's Intrinsic Value: Projected FCF

For the Drug Manufacturers - General subindustry, Quest Laboratories's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Laboratories's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Quest Laboratories's Price-to-Projected-FCF falls into.


;
;

Quest Laboratories Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Quest Laboratories  (NSE:QUESTLAB) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Quest Laboratories's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=84.00/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest Laboratories Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Quest Laboratories's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 45, Sector III, Pithampur Industrial Area, District Dhar, Pithampur, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.

Quest Laboratories Headlines

No Headlines